Hepatitis C Infection Clinical Trials

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
N
Active, not recruiting
  • Chronic Hepatitis
  • Hepatitis C Infection
  • Electroporation-Mediated Plasmid DNA Vaccine Therapy
  • +4 more
  • Jacksonville, Florida
  • +4 more
2022-03-17
Mar 17, 2022
M
Active, not recruiting
  • BCLC Stage B Hepatocellular Carcinoma
  • +10 more
  • Houston, Texas
    M D Anderson Cancer Center
2022-02-25
Feb 25, 2022
A
Recruiting
  • Hepatitis C Infection
  • HIV Infection
  • Glecaprevir/Pibrentasvir (G/P)
  • Ribavirin (RBV)
  • San Diego, California
  • +15 more
2022-01-11
Jan 11, 2022
N
Active, not recruiting
  • Cirrhosis
  • +8 more
  • Laboratory Biomarker Analysis
  • +4 more
  • Scottsdale, Arizona
  • +9 more
2022-01-06
Jan 6, 2022
N
Completed
  • HIV Infection
  • Hepatitis C Infection
  • Nitazoxanide (NTZ)
  • +2 more
  • Birmingham, Alabama
  • +17 more
2021-11-02
Nov 2, 2021
N
Completed
  • Hepatitis C Infection
  • HIV Infection
  • Nitazoxanide With Pegylated Interferon And Ribavirin
  • Washington, District of Columbia
  • +3 more
2021-09-14
Sep 14, 2021
C
Recruiting
  • Hepatitis C Infection
  • Clinical examination
  • Nîmes, France
  • +1 more
2021-08-06
Aug 6, 2021
R
Terminated
  • Hepatitis C Infection
  • Depression
  • Amsterdam, Netherlands
  • +6 more
2020-12-04
Dec 4, 2020
R
Terminated
  • Hepatitis C Infection
  • New York, New York
    Rockefeller University Hospital
2020-02-20
Feb 20, 2020
S
Completed
  • Hepatitis C Infection
  • Heidelberg, Victoria, Australia
  • +3 more
2019-09-17
Sep 17, 2019
I
Completed
  • Hepatitis C Infection
  • HIV
  • Peg-interferon + ribavirin under HIV physician supervision
  • San Pa Tong, Chiang Mai, Thailand
  • +4 more
2019-02-22
Feb 22, 2019
I
Completed
  • Hepatitis C Infection
    • New York, New York
      Icahn School of Medicine
    2019-02-25
    Feb 25, 2019
    I
    Completed
    • Hepatitis C Infection
      • New York, New York
        Icahn School of Medicine at Mount Sinai
      2019-02-01
      Feb 1, 2019
      U
      Completed
      • Hepatitis C Infection
      • AdCh3NSmut1
      • MVA-NSmut
      • Dublin, Ireland
      • +1 more
      2018-10-10
      Oct 10, 2018
      U
      Completed
      • Hepatitis C Infection
      • HIV Infection
      • AdCh3NSmut1
      • +3 more
      • Oxford, Oxfordshire, United Kingdom
        Centre for Clinical Vaccinology and Tropical Medicine
      2018-10-10
      Oct 10, 2018
      C
      Completed
      • Adult Primary Liver Cancer
      • Hepatitis C Infection
      • S-adenosyl-L-methionine disulfate p-toluene-sulfonate
      • +4 more
      • Tucson, Arizona
      • +4 more
      2018-08-09
      Aug 9, 2018
      H
      Completed
      • Hepatitis C Infection
      • ombitasvir/paritaprevir/ritonavir 8 weeks
      • dasabuvir 8 weeks
      • Barcelona, Spain
        Carrion, Jose Antonio, PhD
      2018-05-18
      May 18, 2018
      S
      Terminated
      • Hepatitis C Infection
      • ITX 5061
      • New York, New York
        Mount Sinai School of Medicine
      2018-04-16
      Apr 16, 2018
      S
      Completed
      • Hepatitis C Infection
      • Placebo
      • +3 more
      • San Francisco, California
      • +3 more
      2017-07-18
      Jul 18, 2017
      U
      Terminated
      • Hepatitis C Infection
      • Thrombocytopenia
      • romiplostim
      • +4 more
      • Los Angeles, California
        USC/Norris Comprehensive Cancer Center
      2017-04-09
      Apr 9, 2017